RegeneRx Biopharmaceuticals, Inc.
RegeneRx Biopharmaceuticals, Inc. (RGRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RGRX · as of Jun 9, 2026
Key Statistics
Explore RegeneRx Biopharmaceuticals, Inc. Data
rgrx stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
rgrx competitorsRGRX
BSYI
CHNXF
DRWN
FFNTF
FORZAbout RegeneRx Biopharmaceuticals, Inc.
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and r…
what is regenerx biopharmaceuticals, inc. · rgrx stock overview · regenerx biopharmaceuticals, inc. company profile · who is regenerx biopharmaceuticals, inc. ceo · rgrx OTC · regenerx biopharmaceuticals, inc. headquarters · regenerx biopharmaceuticals, inc. business segments
About Stock Overview & Key Data
RegeneRx Biopharmaceuticals, Inc. (RGRX) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 7, 2003. As of the latest trading session, RGRX stock price is $0.00, with a market capitalization of $898. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, RegeneRx Biopharmaceuticals, Inc. (RGRX) stock price is $0.00. The stock is traded on OTC under the ticker symbol RGRX. The 52-week range is $0.00 – $0.16.